-
-
Policy Matters
Eliminating HPV-Related CancerHPV vaccination and screening can help eradicate cervical cancer and other malignancies.
by Anna R. Giuliano, PhD
-
September 13: The Week in Cancer NewsSome cancer drugs being tested in clinical trials do not work the way researchers thought they did, and ringing a bell following radiation therapy may increase distress for patients.
by Kate Yandell
-
HIV Can Worsen Cancer Treatment OutcomesPeople with HIV who develop certain cancers are more likely to die from them than patients without HIV—even if they receive similar treatment.
by Jon Kelvey
-
Keeping an Eye on CancerImaging tests for post-treatment surveillance may come with radiation exposure, financial strain, “scanxiety” and sometimes unnecessary follow-ups. Doctors and patients need to balance the risks and benefits of scanning.
by Charlotte Huff
-
More Options for Rare CancersPrecision medicine and immunotherapy offer opportunities for new treatments and clinical trials to patients who previously had few, if any, options.
by Kendall K. Morgan
-
The Patient PerspectivePatient-reported outcomes may help shape the future of cancer care.
by Stephen Ornes
-
Healthy Habits
Power OffToo much time spent looking at electronic devices can come at a cost.
by Cameron Walker
-
Q&A
Hope Amid the HypeHematologist-oncologist David Scadden traces the history, promise and uncertainties of treatment advances in Cancerland: A Medical Memoir.
by Marci A. Landsmann
-
Immunotherapy in the ElderlyImmune checkpoint inhibitors can be effective treatments for elderly people with some types of advanced cancer, but more information is needed on their risks and benefits in this group.
by Emma Yasinski
Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.
by Marci A. Landsmann
Understanding Stress and CancerA symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.
by Eric Fitzsimmons
Exploring Amino Acids’ Impact on Tumor GrowthResearchers are investigating how to match specific dietary changes with therapy to impede cancer progression.
by Thomas Celona
Study Shows Minority Participation in Clinical Trials May Be DecliningResearcher speculates that costly genetic testing may be limiting outreach to underserved communities.
by Marci A. Landsmann
-
Using Lymphocytes to Attack TumorsSooner rather than later may be the best strategy for using an experimental treatment for advanced melanoma.
-
Closing Disparities Through Genetic TestingOlufunmilayo Olopade seeks widespread use of testing to encourage prevention and early detection of deadly cancers.
Learning Medicare’s ABCDs
